MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings
The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The product [...]
The post MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings appeared first on Community Pharmacy England.
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest